day 1 retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor Triagonist—Obesity, NAFLD, and T2D Phase 2 Trial Results Retatrutide vs Survodutide: 24% vs

View DSIP (Delta Sleep-Inducing Peptide)

How PlexusDx Makes GLP-1 Affordable Without Insurance Compounded semaglutide injections through PlexusDx are $189/mo month-to-month, or from $149/mo on the 6-month plan across all commitment levelsno escalating costs as your dose increases

Key Features High-Purity Peptide Formulated with premium-grade ingredients and manufactured under strict quality control to deliver consistent purity and research reliability

Your prescribing doctor selects your medication based on multiple factors including effectiveness, side effects, convenience, and insurance coverage, with eye safety being one consideration among many

Notice: Strictly for laboratory research use only

Professional oversight ensures your safety and the effectiveness of your primary treatment plan